SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
73 hedge funds and large institutions have $735M invested in Sage Therapeutics in 2014 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
23% more capital invested
Capital invested by funds: $596M → $735M (+$140M)
Holders
73
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$11.7M | |
| 2 | +$6.96M | |
| 3 | +$5.72M | |
| 4 |
JP Morgan Chase
New York
|
+$4.37M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$3.96M |
Top Sellers
| 1 | -$6.88M | |
| 2 | -$5.06M | |
| 3 | -$4.57M | |
| 4 |
Millennium Management
New York
|
-$2.52M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.91M |